Monoparin (Heparin Sodium)

Heparin Sodium, the active ingredient in Monoparin, is an anticoagulant presented as an injectable solution for intravenous use. It is employed to prevent and treat clot formation in a range of cardiovascular and thromboembolic conditions, particularly in hospitalized and surgical patients. GNH USA supplies Monoparin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Monoparin is an anticoagulant used in the management of thrombotic and cardiovascular disorders. - Venous thromboembolism: prevention and treatment of clot formation in the deep veins and pulmonary arteries. - Deep vein thrombosis prophylaxis: reduces the risk of postoperative DVT in surgical patients. - Acute coronary syndromes: helps to limit clot propagation during unstable angina or myocardial infarction. - Pulmonary embolism: treatment to dissolve existing clots and prevent recurrence.

Heparin Sodium may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Bleeding at injection site: minor bruising or oozing. - Hemorrhage: excessive bleeding from any site. - Thrombocytopenia: reduced platelet count. - Elevated liver enzymes: transient increase in hepatic markers. - Allergic skin reactions: rash or urticaria.

Serious or Rare Side Effects: - Heparin‑induced thrombocytopenia (HIT): immune‑mediated platelet activation. - Major internal bleeding: gastrointestinal or intracranial hemorrhage. - Spinal or epidural hematoma: risk with neuraxial procedures. - Anaphylaxis: severe systemic allergic response.

When using Monoparin, clinicians should consider several safety measures. - Renal impairment: adjust monitoring as clearance may be reduced. - Hepatic dysfunction: observe for altered coagulation parameters. - Concomitant anticoagulants: increase risk of bleeding, require careful dosing. - Recent surgery or trauma: heightened bleeding potential, monitor wound sites. - Pregnancy and lactation: use only if benefit outweighs risk, as safety data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Heparin Sodium can interact with several drug classes, influencing its anticoagulant effect.

Major Interactions (Avoid): - Other anticoagulants (e.g., warfarin, direct thrombin inhibitors): additive bleeding risk. - Neuraxial anesthesia or spinal puncture: increased chance of spinal hematoma. - History of heparin‑induced thrombocytopenia: re‑exposure may trigger severe reaction.

Moderate Interactions (Monitor Closely): - Antiplatelet agents (e.g., aspirin, clopidogrel): enhanced bleeding tendency. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may exacerbate gastrointestinal bleeding. - Certain antibiotics (e.g., vancomycin, aminoglycosides): can potentiate anticoagulant effect.